John Belperio, MD
Specialty
Institutional Affiliation
Languages
Education
Fellowship
Internship
Degree
Residency
Board Certifications
Contact Information
Phone
Clinical Interests
Scientific Interests
Dr. John Belperio's research focuses on 1) lung transplant tolerance to avoid skin cancers post-transplant and 2) pulmonary fibrosis immune mechanisms and how they support lung cancer.
Highlighted Publications
Kolaitis NA, Duffy E, Zhang A, Lo M, Barba DT, Chen M, Soriano T, Hu J, Nabili V, Saggar R, Sayah DM, DerHovanessian A, Shino MY, Lynch JP 3rd, Kubak BM, Ardehali A, Ross DJ, Belperio JA, Elashoff D, Saggar R, Weigt SS. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation. Transpl Int. 2017 Jan;30(1):41-48. doi: 10.1111/tri.12865. Epub 2016 Oct 24.
Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006 Apr;42(6):768-78. Epub 2006 Feb 28. Review.
Pan J, Burdick MD, Belperio JA, Xue YY, Gerard C, Sharma S, Dubinett SM, Strieter RM. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol. 2006 Feb 1;176(3):1456-64.